SuperAPI AI Directory

Geneious

Geneious is bioinformatics software for molecular biology and sequence analysis, comprising two product lines: Geneious Prime and Geneious Biologics. Geneious Prime provides tools for molecular cloning, genomics, antibody screening, and sequence analysis, transforming raw sequence data into understandable charts through an intuitive visual interface, usable without programming; it supports automated workflows, custom algorithms, and integration with existing systems, and enables centralized management of sequence data, notes, and workflows through Geneious Cloud, achieving secure and controllable team collaboration and reducing manual errors. Geneious Biologics is cloud-based antibody discovery and screening software used to simplify the antibody discovery process, and it provides a free online antibody annotation tool that can upload, analyze, and visualize individual IgG-class molecule sequences. In addition, Geneious Academy provides free, unrestricted-access online courses, videos, and tutorials to help master the software and the core concepts of molecular biology, bioinformatics, and antibody discovery. The latest version, Geneious Prime 2026.1, enhances workflows such as Gibson, In-Fusion, Golden Gate, and Parts Cloning, and adds the Doench et al. (2022) on-target algorithm for CRISPR guide scoring.

Open website

About this tool

Geneious is a suite of bioinformatics software for molecular biology and sequence analysis, primarily comprising two products: Geneious Prime and Geneious Biologics.

In terms of purpose, Geneious is used for sequence analysis in bioinformatics and molecular biology research, helping laboratories transform raw sequence data into visual results and usable scientific insights. Its target users include research organizations seeking to improve efficiency, enhance data visibility and insight, and reduce errors and risk.

In terms of main capabilities, Geneious Prime provides the tools needed for molecular cloning, genomics, antibody screening, and sequence analysis, equipped with industry-leading algorithms, powerful analysis capabilities, and visualization features. Users can use it without programming skills. The software supports creating automated workflows, adding custom algorithms, integrating with existing systems, and directly sharing files between Geneious Prime and Geneious Biologics. Geneious Biologics is used to simplify the antibody discovery and screening process, running on intuitive cloud-based software; it also provides a free online antibody annotation tool (Antibody Annotator) for annotating IgG-class molecules, which can upload, analyze, and visualize individual antibody sequences. The Geneious Prime 2026.1 version includes important enhancements to workflows such as Gibson, In-Fusion, Golden Gate, and Parts Cloning, and adds the Doench et al. (2022) on-target algorithm for CRISPR guide scoring.

In terms of usage, Geneious provides an intuitive, user-friendly interface that transforms raw sequence data into meaningful visualizations. Teams can centrally manage sequence data through Geneious Cloud, with data, notes, and workflows made available to peers in a secure, access-controlled manner, thereby improving collaboration. Specific installation commands, system requirements, and operational steps are not currently provided in the available materials.

In terms of learning resources, Geneious Academy provides free, unrestricted-access online courses, including videos and tutorials, covering all aspects of Geneious functionality as well as key concepts in molecular biology, bioinformatics, and antibody discovery.

In terms of applicable scenarios, Geneious is suitable for laboratory work such as molecular cloning, genomics research, antibody discovery and screening, and sequence analysis, and is also suitable for research organizations that need cross-team collaboration, centralized management of sequence dataand reduced manual errors.

In terms of limitations, the available materials do not state whether Geneious is AI-driven, specific fees and pricing, free version limitations, platform support scope, or usage thresholds; this information is not currently provided.